Position in SRRK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,767,364
-$5,651,434 QoQ
Shares Held
219,027
-41.2% QoQ
Ownership
0.183%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94.46460938605743.ToString("F0")%
Shared 0.ToString("F0")%
None 5.535390613942574.ToString("F0")%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. SRRK ranks #129 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in SRRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,767,364 | 219,027 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $16,418,798 | 372,731 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $22,493,031 | 604,002 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $32,033,383 | 904,387 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $27,437,997 | 853,437 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $17,866,495 | 413,385 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $2,190,892 | 273,520 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $2,062,229 | 247,567 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $4,572,397 | 257,455 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $10,982,260 | 584,163 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $1,565,945 | 220,556 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $1,865,807 | 247,455 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,239,568 | 279,946 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,773,884 | 306,507 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,051,589 | 296,045 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,025,608 | 368,964 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $4,844,317 | 375,820 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $8,845,969 | 356,118 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,713,171 | 324,445 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $10,180,050 | 352,251 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $4,326,869 | 85,410 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $12,050,677 | 248,314 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,176,098 | 123,013 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $5,693,883 | 312,679 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,532,248 | 209,104 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||